The CYFIP2 gene helps nerve cells build and adjust the connections they need to send signals through the brain. When it does not work properly, brain signaling and development can be disrupted, which may lead to early seizures, low muscle tone, and delays in learning and movement. This gene plays an important role in the cell’s inner support system, helping growing brain cells move and connect in the right way. Certain harmful variants in the CYFIP2 gene are linked to a rare developmental condition with epilepsy.
What is a gene?
A gene is a stretch of DNA that carries instructions cells use to make molecules or regulate processes throughout the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others are used mainly to control when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
CYFIP2Gene function
What if the gene works
The CYFIP2 gene helps organize a cell's inner skeleton, especially in brain cells. This supports nerve cell growth, branching, and connections needed for normal brain signaling.
Risk
What if the gene does not work
Variants in the CYFIP2 gene can cause developmental and epileptic encephalopathy, with seizures, low muscle tone, and delayed development. Milder to more severe variants may change when symptoms begin and how strongly movement, learning, and behavior are affected.
Treatment
What does that mean for your treatment
No CYFIP2-specific treatment or management approach is currently established.
Conditions associated with CYFIP2
Gene function
What if the gene works
In everyday cell life, the CYFIP2 gene helps cells organize their inner framework and control when certain proteins are made. This matters most in nerve cells, where shape, growth, and communication depend on tightly timed signals. Understanding how the CYFIP2 gene works helps you see how cells build connections during brain development and daily signaling.
The CYFIP2 gene helps control actin, a protein that forms part of a cell’s inner framework. Through its protein, it links outside signals to changes in cell shape and structure.
Its protein works within a helper group called the WAVE complex, which turns cell signals into controlled actin building. This helps cells move, spread, and make stable contacts. In nerve cells, it supports growing branches and connection points.
The CYFIP2 gene also helps fine tune translation (the step where cells read RNA to make protein). By doing so, it supports balanced protein production at the right place and time.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many disease causing variants in the CYFIP2 gene change a single building block in the protein, altering its shape or its grip on partner proteins and often leaving this cell control system too active. Some CYFIP2 gene variants linked to epilepsy have a stronger effect, while others are milder or reduce the amount of protein made. This range in functional impact can influence how early developmental and seizure related features begin and how marked they are.
How variants are linked to conditions
Pathogenic variants in the CYFIP2 gene can cause developmental and epileptic encephalopathy, a condition that usually starts in infancy with seizures and delayed development. Many affected children also have intellectual disability, low muscle tone, feeding difficulties, or movement differences. This is the main well-established CYFIP2 gene link to epilepsy and neurodevelopmental symptoms reported in human genetics.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible association rather than a definite diagnosis, particularly when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CYFIP2, risk is mainly linked to having a disease-causing change in the gene, and most known cases happen as a new change rather than being passed down. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully increase or lower the chance of having a CYFIP2-related condition.
Inheritance of CYFIP2 variants
CYFIP2-related conditions are usually inherited in an autosomal dominant pattern, which means one altered copy of the CYFIP2 gene can be enough to cause the condition. A parent carrying a disease-causing variant has a 50% chance of passing it on in each pregnancy. In many families, though, CYFIP2 gene inheritance involves a new (de novo) variant that appears for the first time in the child and was not inherited from either parent. Sons and daughters can inherit it equally.
What does my CYFIP2 result mean for my family?
For CYFIP2, the main known pattern is dominant, which means close relatives such as parents, brothers, sisters, and children could also carry the same change. In many living with a CYFIP2-related condition, the change happened new in the child and was not inherited from either parent. Even so, family testing can sometimes help clarify who else in the family may be affected or at risk of passing it on.
Genetic information
Genetic testing
How you find out about variants
To find out whether you have a change in the CYFIP2 gene, doctors use genetic testing for CYFIP2 variants on a blood or saliva sample. The lab reads the DNA sequence, often through an epilepsy panel or exome test, and compares it with known variants. Results may show a pathogenic variant, a benign variant, or an unclear result.
When should I consider getting a genetic test?
Genetic testing for the CYFIP2 gene may be worth considering when a baby or young child has unexplained early seizures, delayed development, low muscle tone, or feeding problems. It can help find a genetic cause for a severe epilepsy condition and guide care and family counseling.
A genetic result is only one part of your health story
Genetic testing can provide valuable insight, but how much it can clarify varies depending on the condition and the specific variant. Over time, factors such as lifestyle, environment, age, and medical history also affect how the body functions. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines, so the same treatment may work differently from one person to another. Some people break down a drug faster or slower, while others are more or less sensitive to its effects. These common differences can influence how well a medicine works and how likely side effects are. Medication response is also shaped by factors like age, liver and kidney function, and other medicines you take.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It looks at connections between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug acts and how the body processes it. This understanding can help support more informed and more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the CYFIP2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so any concerns about medicines, side effects, or changes in your health are best discussed with your doctor. This is especially important before starting a new treatment or if a medicine does not seem to be working as expected.
History
In the late 1990s, researchers identified the CYFIP2 gene while studying proteins that interact with FMRP, a protein already important in fragile X research. Early work placed CYFIP2 in a growing group of genes involved in how nerve cells organize their internal structure and connections. From these first observations, research expanded steadily, and scientists mapped CYFIP2 more clearly within pathways that help brain cells develop and communicate. Interest in the gene increased further when de novo variants, meaning new variants not inherited from a parent, were linked to severe early onset epilepsy and developmental conditions in children. More recent studies have refined how doctors and researchers recognize CYFIP2 related conditions.